CADL (Candel Therapeutics) Yalpi foyda marjasi

Candel Therapeutics (CADL) korporativ emblemasi va logotipi

Candel Therapeutics onkologiyaga qarshi kurashish uchun virusli immunoterapiyani ishlab chiqayotgan ambitsiyali innovatordir. Ushbu yalpi foyda grafigi ushbu yondashuvning samaradorligini aniq ko'rsatadi, bunda 0.00 oxirgi metrika darajasini aks ettiradi. Biznes sinovlarni tezlashtirish uchun molekulalarni robotlashtirilgan skrining qilishga tayanadi. Bundan tashqari, dori vositalarini ishlab chiqish butunlay no-tsikllidir, bu esa kompaniyaga har qanday makroiqtisodiy zarbalarga yuqori chidamlilikni ta'minlaydi.

CADL: Candel Yalpi foyda bo'yicha rentabellik 04.07.2022 - 20.11.2026

Candel (CADL) moliyaviy va bozor koʻrsatkichlari kesimi

Fundamental baholash:CADL candeltx.com
Candel Therapeutics Inc. yetakchi tovari

Professional kapital Candel Therapeutics (CADL) profilini onkolitik platformalarning yirik sog'liqni saqlash gigantlari grantlari bilan qo'llab-quvvatlangan yuqori qo'shimcha qiymat yaratish qobiliyati prizmasi orqali baholaydi. Valoviy marjani tahlil qilish orqali investor tushumning bevosita ishlab chiqarish xarajatlari chegirilgan qismini aniqlaydi, bu esa ushbu egri chiziq dinamikasi orqali aktivning operatsion samaradorligini va bozor tebranishlari fonidagi fundamental barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik